Riskpilot← Back to searchSign inGet full accessIréne Savvidou AB
ABActiveOrg 5592087299Honnörsgatan 4Medical specialists activities · NACE 8622Est. 20190 employees
Revenue 2025
SEK 0
EBITDA margin
—
-294% vs 2024
Equity ratio
91.0%
Financial strength
Net profit 2025
SEK 1,5M
-33% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -56K | -294% |
| Net profit | SEK 1,5M | -33% |
| Total assets | SEK 8,7M | +4% |
| Equity | SEK 7,9M | +11% |
| Employees | 0 | — |
Legal name
Iréne Savvidou AB
Org number
5592087299
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 juni 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget skall bedriva hälso- och sjukvård inom gynekologi och obstetrik samt därmed förenlig verksamhet.
Address
Honnörsgatan 4
Email
isavvidou50@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 | −11 | 23 | 29 | −56 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −8 | −11 | 23 | 29 | −56 |
| Net financials | — | 2 500 | 2 200 | 2 195 | 1 485 |
| Profit before tax | −8 | 2 489 | 2 223 | 2 223 | 1 519 |
| Tax | −0 | −0 | −1 | −6 | −23 |
| Net profit | −8 | 2 489 | 2 222 | 2 217 | 1 496 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 955 | 4 966 | 6 942 | 8 365 | 8 690 |
| Equity | 1 921 | 3 821 | 5 493 | 7 110 | 7 907 |
| Long-term debt | −162 | — | — | — | — |
| Short-term debt | 1 106 | 1 054 | 1 358 | 1 164 | 783 |
| Total debt | 944 | 1 054 | 1 358 | 1 164 | 783 |
EBITDA margin
-5601700.0%
This company
15.8%
Market median
-35453897% vs market
20212025
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
20212025
Return on equity
18.9%
This company
18.4%
Market median
+3% vs market
20212025
Net profit margin
149639900.0%
This company
8.1%
Market median
+1847406073% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MH | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Iréne Savvidou AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Helena Fälton Björkman | Audit | 0 companies |
| Johanna C E Gyllenkahl | Deputy Board Member | 0 companies |
| Iréne Ulla Elisabeth Savvidou | Board of Directors | 0 companies |